ECP as a marker of eosinophil activation showed a decrease resulting from the treatment, which can possibly indicate that although the absolute eosinophil count is not out of the limits, eosinophil priming is still present in patients with UACS, some of them with underlying allergic rhinitis and atopy. This evidence concerns the gene RNASE3 and allergic rhinitis.